Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links

About FDA

-

Controlled Substances Staff Presentations

Presentations

PhRMA-FDA Dialogue Session. February 20, 2008

PhRMA-FDA Dialogue Session Abuse Potential Assessments
- Panel Responses and Discussions (PDF-639 KB)
- Hypothetical Case Studies for Panel Discussion (PDF-656 KB)
  - Transcript of the Case Studies (PDF-669 KB)

Drug Information Association Workshop, June 18, 2003:

"Abuse Liability Assessment and Drug Scheduling: An Overview (PDF-95KB)." Deborah Leiderman, M.D., M.A.
"The Assessment of Abuse Liability: The Regulatory Perspective. (PDF-60KB)" Silvia N. Calderon-Gutkind, Ph.D.
"Incorporating the Assessment of Abuse Liability into the Drug Discovery and Development Process. (PDF-95KB)" Robert S. Mansbach, Ph.D., Pfizer Global Research and Development.

-

-